Wael Jdey

Wael Jdey

Company: Onxeo

Job title: Lead Scientist


Drug-driven HRD: From Bench to Bedside & Back: Discovering Novel Biomarkers for PARP 9:30 am

Understanding and utilizing drug-driven Homologous Recombination Deficiency (HRD) Potentials and hope for a Rad51 biomarker Furthering the understanding of primary and acquired resistance to PARP inhibitorsRead more

day: Day Two

Breakfast Panel: Assessing the Situation: Improving Biomarker Characterization, Aiding Predictive Drug Development & Advancements in Addressing Patient Heterogeneity 8:00 am

Discussing target engagement and response biomarkers Exploring similarities between uses of biomarkers in pre-clinical vs clinical settings Debating the reliability of current biomarkers Is a global standard approach needed to evaluate biomarkers? How would we navigate this? Dissecting selecting alternative biomarkers for various populations How close to the route cause should we be going? (genomics,…Read more

day: Day Two

Panel Discussion: PARPi’s: The Whole Story? PARP & DDR Biomarkers, Targets & Hope in Indications Outside of Breast & Ovarian 9:30 am

Sharing insights into future directions and what to anticipate as standards evolve for PARP and other DDRi’s in the clinic How is it looking for prostate? leukemia? GBM? pancreatic? endometrial? SCLC? What are the differences between cancers in terms of resistance to PARP inhibitors? Thoughts on moving to a more genomic rather than indication-specific biomarker-driven…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.